Isoflurane post-treatment improves pulmonary vascular permeability via upregulation of heme oxygenase-1

Exp Lung Res. 2013 Sep;39(7):295-303. doi: 10.3109/01902148.2013.817627. Epub 2013 Aug 6.

Abstract

Isoflurane (ISO) has been shown to attenuate acute lung injury (ALI). Induction of heme oxygenase-1 (HO-1) and suppression of inducible nitric oxide synthase (iNOS) expression provide cytoprotection in lung and vascular injury. The aim of this study was to investigate the effect of post-treatment with isoflurane on lung vascular permeability and the role of HO-1 in an ALI rat model induced by cecal ligation and puncture (CLP). Male Sprague-Dawley rats were randomly assigned to one of four groups: sham group, sham rats post-treated with vehicle (Sham); CLP group, CLP rats post-treated with vehicle (CLP); ISO group, CLP rats post-treated with isoflurane (ISO); and ZnPP group, CLP rats injected with zinc protoporphyrin IX (ZnPP), a competitive inhibitor of HO-1, 1 hour before the operation, and post-treated with isoflurane (ZnPP). Isoflurane (1.4%) was administered 2 hour after CLP. At 24 hour after CLP, the extent of ALI was evaluated by lung wet/dry ratio, Evans blue dye (EBD) extravasation, lung permeability index (LPI), as well as histological and immunohistochemical examinations. We also determined pulmonary iNOS and HO-1 expression. Compared with the CLP group, the isoflurane post-treatment group showed improved pulmonary microvascular permeability as detected by EBD extravasation, LPI, as well as histological and immunohistochemical examinations. Furthermore, isoflurane decreased iNOS and increased HO-1 expression in lung tissue. Pretreatment with ZnPP prevented the protective effects of isoflurane in rats. These findings indicate that the protective role of isoflurane post-conditioning against CLP-induced lung injury may be associated with its role in upregulating HO-1 in ALI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / drug therapy
  • Acute Lung Injury / etiology
  • Acute Lung Injury / metabolism*
  • Animals
  • Capillary Permeability / drug effects*
  • Disease Models, Animal
  • Heme Oxygenase-1 / antagonists & inhibitors
  • Heme Oxygenase-1 / drug effects
  • Heme Oxygenase-1 / metabolism*
  • Isoflurane / pharmacology*
  • Isoflurane / therapeutic use
  • Lung / blood supply*
  • Lung / drug effects
  • Lung / metabolism
  • Male
  • Nitric Oxide Synthase Type II / metabolism
  • Protoporphyrins / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis / complications
  • Up-Regulation / drug effects*

Substances

  • Protoporphyrins
  • zinc protoporphyrin
  • Isoflurane
  • Nitric Oxide Synthase Type II
  • Heme Oxygenase-1